Dystonia and headaches: clinical features and response to botulinum toxin therapy.
D000328:Adult; D000368:Aged; D001764:Blepharospasm / Q000188:drug therapy / Q000503:physiopathology; D001905:Botulinum Toxins / Q000009:adverse effects / Q000627:therapeutic use*; D004421:Dystonia / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006261:Headache / Q000209:etiology*; D006801:Humans; D007571:Jaw Diseases / Q000188:drug therapy / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000502:physiology; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010146:Pain / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D010147:Pain Measurement; D012720:Severity of Illness Index; D014103:Torticollis / Q000188:drug therapy / Q000503:physiopathology
D009465:Neuromuscular Agents; D001905:Botulinum Toxins